C50H54F3N7O7S — CID 168875943
N-[[1-[12-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxydodecyl]-4-(4-phenyl-1,3-thiazol-2-yl)piperidin-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (PubChem CID 168875943) has the molecular formula C50H54F3N7O7S and a molecular weight of 954.08 g/mol. Its IUPAC name is N-[[1-[12-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxydodecyl]-4-(4-phenyl-1,3-thiazol-2-yl)piperidin-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide.
| Compound Name | N-[[1-[12-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxydodecyl]-4-(4-phenyl-1,3-thiazol-2-yl)piperidin-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide |
|---|---|
| PubChem CID | 168875943 |
| Molecular Formula | C50H54F3N7O7S |
| Molecular Weight | 954.08 g/mol |
| Exact Mass | 953.38 |
| IUPAC Name | N-[[1-[12-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxydodecyl]-4-(4-phenyl-1,3-thiazol-2-yl)piperidin-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide |
| SMILES | O=C1CCC(N2C(=O)c3cccc(OCCCCCCCCCCCCN4CCC(CNC(=O)c5cccc(-c6noc(C(F)(F)F)n6)c5)(c5nc(-c6ccccc6)cs5)CC4)c3C2=O)C(=O)N1 |
| InChI | InChI=1S/C50H54F3N7O7S/c51-50(52,53)47-57-42(58-67-47)34-18-14-19-35(30-34)43(62)54-32-49(48-55-37(31-68-48)33-16-10-9-11-17-33)24-27-59(28-25-49)26-12-7-5-3-1-2-4-6-8-13-29-66-39-21-15-20-36-41(39)46(65)60(45(36)64)38-22-23-40(61)56-44(38)63/h9-11,14-21,30-31,38H,1-8,12-13,22-29,32H2,(H,54,62)(H,56,61,63) |
| InChIKey | QZTIYFLFKSBTNW-UHFFFAOYSA-N |
| XLogP | 9.02 |
| TPSA | 176.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 68 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 954.08 |
| LogP ≤ 5 | 9.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|